v3.25.2
Fair value measurement (Tables)
6 Months Ended
Jun. 30, 2025
Fair value measurement  
Schedule of assets and liabilities measured at fair value on recurring basis

   

Quoted prices
in active
markets
(Level 1)

   

Significant
other
observable
inputs
(Level 2)

   

Significant
unobservable
inputs
(Level 3)

   

Total

   

Classification in Consolidated
balance sheets

(in thousands)

At December 31, 2024

Assets:

Cash and cash equivalents

$

158,930

$

$

$

158,930

Cash and cash equivalents

Restricted cash

1,399

1,399

Other non-current assets

Total assets

$

160,329

$

$

$

160,329

Liabilities:

Contingent consideration

10,860

10,860

Contingent consideration

Consideration for post-acquisition services

370

370

Other non-current liabilities

Total liabilities

$

$

$

11,230

$

11,230

At June 30, 2025

Assets:

Cash and cash equivalents

$

253,778

$

$

$

253,778

Cash and cash equivalents

Restricted cash

1,494

1,494

Other non-current assets

Total assets

$

255,272

$

$

$

255,272

Liabilities:

Contingent consideration

15,931

15,931

Contingent consideration

Consideration for post-acquisition services

542

542

Other non-current liabilities

Total liabilities

$

$

$

16,473

$

16,473

Schedule of changes in fair value of contingent consideration

Amount of

contingent

consideration

   

2025

(in thousands)

Balance at December 31, 2024

$

10,860

Unrealized change in fair value (presented within research and development expenses)

3,470

Currency translation effects

1,601

Balance at June 30, 2025

$

15,931